Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,833 | 4,145 | 2,824 | 3,529 | 4,603 |
| Receivables | N/A | N/A | N/A | N/A | 12 |
| TOTAL | $2,888 | $4,231 | $2,932 | $3,714 | $4,858 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 35 | 35 | 83 | 95 | 74 |
| TOTAL | $35 | $35 | $83 | $95 | $74 |
| Total Assets | $2,923 | $4,267 | $3,016 | $3,809 | $4,932 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 723 | 693 | 782 | 636 | 539 |
| Accrued Expenses | N/A | N/A | 15 | 15 | 15 |
| TOTAL | $723 | $693 | $797 | $652 | $558 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $723 | $693 | $797 | $652 | $558 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,814 | 16,561 | 14,781 | 14,781 | 14,781 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -29,138 | -26,738 | -24,694 | -23,003 | -21,285 |
| TOTAL | $2,200 | $3,574 | $2,219 | $3,157 | $4,374 |
| Total Liabilities And Equity | $2,923 | $4,267 | $3,016 | $3,809 | $4,932 |